Functional Disorder: Clinical Trials

5 trials for Functional Disorder, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 active not recruiting, 2 completed, 1 recruiting. 2 Not applicable, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable2Active not recruiting 1, Completed 1
Phase 41Recruiting 1

Follow Functional Disorder: new trials by email Literature Review of Functional Disorder trials Research Report on Functional Disorder

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Patient Education and Duloxetine, Alone and in Combination, for Patients With Multisystem Functional Somatic Disorder
Patient Education, Duloxetine, Benztropine Mesylate 0.5 MG and passive placebo RAP - Functional Disorder
Phase 4RecruitingAarhus University Hospital4242024-01-012024-01-30
The Pilot of the Turku Outpatient Clinic for Functional and Fatigue Disorders
Biopsychosocial, multidisciplinary, and individually tailored rehabilitation for patients with persisten symptoms - Persistent Physical Symptoms (PPS), Functional Disorder
Active not recruitingTurku University Hospital1252023-08-012025-12-09
Central Processing of Odour Stimuli in Patients With Functional Somatic Disorder, MCS or Post Covid Compared to Healthy Controls
MRI and paraclinical tests - Functional Disorder, Bodily Distress Syndrome
Not applicableActive not recruitingUniversity of Aarhus402021-11-022025-05-08
Investigating Drop Attacks
Semi-structured interview, Drop attack diary - Functional Disorder
CompletedUniversity of Edinburgh72018-07-202020-03-06
Feasibility and Pilot Testing of Group-based ACT for Adolescents With Functional Somatic Syndromes
Acceptance and Commitment Therapy - Functional Disorder
Not applicableCompletedUniversity of Aarhus212013-05-292021-06-14

Narrower conditions

Fatigue Syndrome, Chronic (1)  ·  Medically Unexplained Symptoms (1)  ·  Multiple Chemical Sensitivity (1)

Broader conditions

Pathological Conditions, Signs and Symptoms (2)  ·  Chronic Disease (1)  ·  Disease Attributes (1)  ·  Disorders of Environmental Origin (1)  ·  Encephalomyelitis (1)  ·  Environmental Illness (1)  ·  Hypersensitivity (1)  ·  Immune System Diseases (1)  ·  Muscular Diseases (1)  ·  Musculoskeletal Diseases (1)  ·  Nervous System Diseases (1)  ·  Neuroinflammatory Diseases (1)  ·  Neuromuscular Diseases (1)  ·  Pathologic Processes (1)  ·  Signs and Symptoms (1)

Interventions

Acceptance and Commitment Therapy (1)  ·  Benztropine (1)  ·  Duloxetine Hydrochloride (1)  ·  Magnetic Resonance Imaging (1)  ·  Patient Education as Topic (1)  ·  Serotonin and Noradrenaline Reuptake Inhibitors (1)

Sponsors

University of Aarhus (2)  ·  Aarhus University Hospital (1)  ·  Turku University Hospital (1)  ·  University of Edinburgh (1)

Countries

Denmark (2)  ·  Finland (1)  ·  United Kingdom (1)

Top investigators

Charlotte U Rask, MD, PhD (1)  ·  Lise Gormsen, PhD (1)  ·  Lise K Gormsen, MD, PhD (1)

Results publications

PMID 32957944, PMID 38604496